Insider Buyers At Taysha Gene Therapies Sitting On US$24m Profit [Yahoo! Finance]
Taysha Gene Therapies, Inc. (TSHA)
Company Research
Source: Yahoo! Finance
After accounting for the recent loss, the US$16.2m worth of shares they purchased is now worth US$40.1m, suggesting a good return on their investment. While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, logic dictates you should pay some attention to whether insiders are buying or selling shares. See our latest analysis for Taysha Gene Therapies Taysha Gene Therapies Insider Transactions Over The Last Year The Board Observer Paul Manning made the biggest insider purchase in the last 12 months. That single transaction was for US$15m worth of shares at a price of US$0.90 each. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of US$2.24. While it does suggest insiders consider the stock undervalued at lower prices, this transaction doesn't tell us much about what they think of current prices. Happily, we note that in the last year in
Show less
Read more
Impact Snapshot
Event Time:
TSHA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TSHA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TSHA alerts
High impacting Taysha Gene Therapies, Inc. news events
Weekly update
A roundup of the hottest topics
TSHA
News
- Taysha Gene Therapies, Inc. (NASDAQ: TSHA) had its price target lowered by analysts at Piper Sandler from $9.00 to $7.00. They now have an "overweight" rating on the stock.MarketBeat
- Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $5.00 price target on the stock.MarketBeat
- Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded WarrantsGlobeNewswire
- Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]Yahoo! Finance
- Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsGlobeNewswire
TSHA
Earnings
- 5/14/24 - Beat
TSHA
Sec Filings
- 7/1/24 - Form 4
- 6/26/24 - Form 8-K
- 6/26/24 - Form 424B5
- TSHA's page on the SEC website